Perchenet L, Hilfiger L, Mizrahi J, Clément-Chomienne O
Preclinical Research, F. Hoffmann-La-Roche Ltd., Basel, Switzerland.
J Pharmacol Exp Ther. 2001 Sep;298(3):1108-19.
Appetite suppressants have been associated with primary pulmonary hypertension (PPH), inhibition of voltage-gated potassium channels, membrane depolarization, and calcium entry in pulmonary artery smooth muscle cells. In cells taken from pulmonary arteries of primary pulmonary hypertensive patients, voltage-gated potassium channels appear to be dysfunctional and in particular, reduced hKv1.5 gene transcription and hKv1.5 mRNA instability have been shown. We have compared the effects of anorexinogen agents on hKv1.5 channels stably expressed in mammalian cell line. We found that aminorex, phentermine, dexfenfluramine, sibutramine, and fluoxetine cause a dose-dependent inhibition of hKv1.5 current. Aminorex, phentermine, and dexfenfluramine had a K(D) of inhibition greater than to 300 microM and are not potent inhibitors of hKv1.5. Sibutramine and fluoxetine inhibited hKv1.5 current with lower K(D) values of 41 and 21 microM, respectively. Block by both drugs increased rapidly between -20 and +10 mV, coincident with channel opening and suggested an open channel block mechanism. This was confirmed by a slower deactivation time course resulting in a "crossover" phenomenon when tail currents recorded under control conditions and in the presence of either drug were superimposed. Single channel experiments demonstrated that open probability and open duration of hKv1.5 were decreased by fluoxetine and sibutramine. These results indicate that among the anorexinogen agents tested, sibutramine and fluoxetine are the most potent toward hKv1.5 channel, which they preferentially block in the open state. Nevertheless, their inhibitory effects do not correlate with their ability to produce PPH neither with their previously reported therapeutic plasma concentrations.
食欲抑制剂与原发性肺动脉高压(PPH)、电压门控钾通道抑制、膜去极化以及肺动脉平滑肌细胞中的钙内流有关。在取自原发性肺动脉高压患者肺动脉的细胞中,电压门控钾通道似乎功能失调,特别是已显示hKv1.5基因转录减少和hKv1.5 mRNA不稳定。我们比较了食欲抑制剂对稳定表达于哺乳动物细胞系中的hKv1.5通道的影响。我们发现氨基苯丙胺、芬特明、右芬氟拉明、西布曲明和氟西汀会引起hKv1.5电流的剂量依赖性抑制。氨基苯丙胺、芬特明和右芬氟拉明的抑制解离常数(K(D))大于300 microM,并非hKv1.5的强效抑制剂。西布曲明和氟西汀分别以较低的K(D)值41和21 microM抑制hKv1.5电流。两种药物的阻断作用在-20至+10 mV之间迅速增加,与通道开放一致,提示为开放通道阻断机制。当在对照条件下和存在任一药物时记录的尾电流叠加时,较慢的失活时间进程导致“交叉”现象,从而证实了这一点。单通道实验表明,氟西汀和西布曲明降低了hKv1.5的开放概率和开放持续时间。这些结果表明,在所测试的食欲抑制剂中,西布曲明和氟西汀对hKv1.5通道的作用最强,它们优先在开放状态下阻断该通道。然而,它们的抑制作用与产生PPH的能力以及先前报道的治疗血浆浓度均无关。